1.The Efficacy of Laparoscopic Burch Colposuspension for Female Stress Urinary Incontinence.
Jeong Hee HONG ; Seong Soo JEON ; Kyu Sung LEE
Korean Journal of Urology 2000;41(4):560-565
No abstract available.
Female*
;
Humans
;
Urinary Incontinence*
2.Effect of Radiation Therapy on Atelectasis from Lung Cancer.
Seong Eon HONG ; Young Ki HONG
Journal of the Korean Society for Therapeutic Radiology 1990;8(1):73-78
From January 1981 to December 1989, total 42 patients with atelectasis from lung cancer were treated with radiation therapy at the Department of Therapeutic Radiology in Kyung Hee University Hospital. The reexpansion of atelectasis after radiotherapy of the lung was evaluated retrospectively, utilizing treatment records and follow-up chest radiographs. Of the patients with non-small cell carcinoma of the lung, the response rate was 62% (21/34). Patient with small cell carcinoma showed a 75% (6/8) response rate. There appears to be some evidence of a relationship of total tumor dose versus response of atelectasis; radiation dose over 40 gy (1337 ret), had a favorable effect on the rate of response compared with that below 40 gy (1297 ret), 70% (21/30) and 50% (6/12), respectively (p<0.01). Total response rate (partial and complete responses) of all patients was 64% (27/42). Franction size was not contributed to the difference of response rates between small fraction (180~200 cgy) and large fraction (300 cgy), 53% (14/22) and 65% (13/20), respectively. The results of this study suggest that radiation therapy has a definite positive role in management of atelectasis caused by lung cancer, especially in inoperable non-small cell carcinoma.
Carcinoma, Small Cell
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Pulmonary Atelectasis*
;
Radiation Oncology
;
Radiography, Thoracic
;
Radiotherapy
;
Retrospective Studies
3.Efficacy of Bee Venom Injection for Osteoarthritis Patients.
Choong Hee WON ; Eui Seong CHOI ; Seong Sun HONG
The Journal of the Korean Rheumatism Association 1999;6(3):218-226
OBJECTIVES: Bee venom contains a potent antiinflammatory peptide 401 as well as mellitin. The purpose of this study was to see the efficacy and safety of purified bee venom injection therapy for knee or spinal osteoarthritis patients. METHODS: One hundred and one osteoarthritis patients were randomly assigned to bee venom injection therapy or oral nabumetone medication group. Bee venom injection group was subdivided into 3 groups according to different dosing schedule(group A: gradual increase up to 0.7mg, group B: up to 1.5mg and group C: up to 2.0mg). Control group patients(group D) were given 1000mg nabumetone daily for 6 weeks. There were 25, 26, 25, and 26 patients assigned to A, B, C, or D group. The efficacy of treatment was evaluated by measuring instruments developed by authors, and the safety of bee venom injection was evaluated by hematology and chemistry laboratory examination. RESULTS: Among 101 patients, eighty-one patients completed the study, but twenty patients were dropped out and two of these patients were dropped out due to adverse drug reaction. The efficacy in bee venom group showed better improvement than nabumetone group(p<0.01). Within bee venom group, group B and C showed better improvement than group A(p<0.01). Itching around injection site occurred in most patients, and bodyache occurred in 49 patients (81.7%). Hemoglobin was decreased(0.3g/dl) in group C, but no significant changes were observed in other laboratory values. CONCLUSION: The efficacy of bee venom injection in the control of knee or back pain in osteoarthritis patients was better than nabumetone medication. No severe allergic or adverse reaction was observed in bee venom treatment patients, but problems related with bee venom injection, such as pruritis, bodyache, and the possibility of anaphylaxis, should be considered for the use of bee venom injection.
Anaphylaxis
;
Back Pain
;
Bee Venoms*
;
Bees*
;
Chemistry
;
Drug-Related Side Effects and Adverse Reactions
;
Hematology
;
Humans
;
Knee
;
Melitten
;
Osteoarthritis*
;
Osteoarthritis, Spine
;
Pruritus
4.A Case of Congenital Hemangiopericytoma of Small Bowel Associated with Intestinal Obstruction.
Ki Min KIM ; Seong Hee PARK ; Eun Jeong KIM ; Ki Hong PARK ; Byung Heon KIM ; Seong Ryul RYU
Journal of the Korean Society of Neonatology 1997;4(2):276-279
Hemangiopericytoma was first described by Stout & Murray in 1942 and was an uncommon soft tissue tumor thought to be derived from vascular pericytes. Approximately 10-15% of the cases occur in children have a propensity to develop in the region of head, neck and lower extremities. We experienced a case of congenital hemangiopericytoma of small bowel in a male neonate who showed vomiting and abdorninal distension. We reported a case of congenital hemangiopericytoma of small bowel with brief review of related literature.
Child
;
Head
;
Hemangiopericytoma*
;
Humans
;
Infant, Newborn
;
Intestinal Obstruction*
;
Intestine, Small
;
Lower Extremity
;
Male
;
Neck
;
Pericytes
;
Vomiting
5.Congenital Partial Left Pericardial Defect.
Seong Jin HONG ; Seong Woo KIM ; Young Hyuk LEE ; Min Hee KIM ; Kyo Sun KIM ; Jung Yun CHOI
Korean Circulation Journal 1996;26(3):752-756
Congenital pericardial defect is relatively rare and two different types, partial and complete, of different clinical significance have been recognized. Most reported defects are complete type and left-sided lesion. Most patients are asymptomatic or complain of vague chest pain. Partial pericardial defect can be potentially fatal due to cardiac herniation and strangulation or coronary insufficiency. Plain chest reontgenography shows abnormal prominence along the cardiac border. 2-D echocardiography demonstrates a drop-off of pericardial echo and protruding cardiac chamber through the defect. Because of the potential fatality, surgical repair is recommended for the partial pericardial defect. We report a case of congenital partial left pericardial defect, which was diagnosed by plain chest reontgenography and 2-D echocardiography, with related literatures.
Chest Pain
;
Echocardiography
;
Humans
;
Thorax
6.Radiation Therapy In Management Of Primary Non-Hodgkin's Lymphoma Of Central Nervous System.
Journal of the Korean Society for Therapeutic Radiology 1994;12(1):33-42
From 1982 to 1991, sixteen patients with primary on-Hodgkin's lymphoma of the central nervous system (CNS) were seen at Kyung Hee University Hospital. The most common subtypes were large, noncleaved cell lymphoma and immunoblastic lymphoma of B cells. Lesions most commolnly involved were the parietal lobes and/or deep nuclei. Positive cerebrospinal fluid cytology was rare at initial presentation. Sixteen patients were treated with surgical biopsy or resection followed by whole brain radiotherapy at a median dose of 40 Gy(range=30-50 Gy) with variable boost doses. Of 16 patients who underwent surgery and postoperative radiotherapy, fourteen patients died between 2 and 49 months following treatment, and two are alive with no evidence of disease at 8 and 22 months. The 1-and 2-year survival rates were 55.6% and 34.7% respectively with 12 months of median survival. Patterns of failure were analyzed in eleven patients of total 16 patients. Failure at the original site of involvement was uncommon after radiotherapy treatment. In contrast, failure in the brain at sites other than those originally involved was common in spite of the use of whole brain irradiation. Failure occurred in the brain 11/16(68.7%), in spinal axis 4/16(25.0%). The age, sex. Location of involvement within CNS, numbers of lesion, or radiation dose did not influence on survival. The authors conclude that primary CNS lymphoma is a locally aggressive disease that is poorly controlled with conventional radiation therapy. The limitation of current therapy for this disease are discussed, and certain promising modality should be made in regarding the management of future patients with this disease.
Axis, Cervical Vertebra
;
B-Lymphocytes
;
Biopsy
;
Brain
;
Central Nervous System*
;
Cerebrospinal Fluid
;
Humans
;
Lymphoma
;
Lymphoma, Non-Hodgkin*
;
Parietal Lobe
;
Radiotherapy
;
Survival Rate
7.Dose-Response Curves of Mouse Jejunal Crypt Cells by Multifrationated Irrdiation.
Journal of the Korean Society for Therapeutic Radiology 1986;4(2):89-98
Using as assay for jejunal crypt stem cell survival, dose-response curves for the reproductive capacity of crypt stem cells mouse jejunum exposed to multifractionated gamma-ray irradiation(single, 2, 3, 4, 5, 6, 7, 8, 10,12, and 16 fractions) were analyzed and single-dose survival curve of these cells was constructed. The following conclusion were drawn: 1) Survival curves for higher numbers of dose fractions were displaced to higher dose, and characterized by increasingly shallower slopes. 2) The single-dose survival curve had broad shoulder, Dq=460 cGy, remaining near-exponential over initial dose range 0 to 300 cGy, with initial slope 1Do=474 cGy 3) At fractionated dose in the range of 180 to 450 cGy, the average recovered dose per fraction interval was approximately 50% of the dose per fraction. 4) The value of a/b ratio by using of linear regression analysis for the reciprocal dose plots was 8.3Gy which lied in the range of 6-14Gy for early-reacting tissues. 5) The linear-quadratic model for dose-response formula offers valid approximations for all doses to be used in radiotherapy, only two parameters to be determined, and considerable convenience in practical applications.
Animals
;
Jejunum
;
Linear Models
;
Mice*
;
Radiotherapy
;
Shoulder
;
Stem Cells
8.Prognostic Factors in Patients with Vrain Metastases from Non-Small Cell Lung Carcinoma.
Journal of the Korean Society for Therapeutic Radiology 1991;9(2):197-204
A retrospective study of 53 patients suffering from non-small cell carcinoma of lung with brain metastases is presented. They were treated in the Department of Therapeutic Radiology of Kyung Hee University Hospital from 1983 to 1990. There were 37 male and 16 female patients. The age range was 39 to 85 years (median=59). The most common histologic cell type of tumor was adenocarcinoma (50.9%), followed by squamous cell carcinoma and large cell carcinoma. All patients were treated with whole-brain photon irradiation(WBI) using lateral opposing fields. The overall median survival time was 5 months. Age, sex, histologic type, and initial performance status were not prognostically important. The most important prognostic factors were the response to radiotherapy and the presence of brain metastases alone. Lncreasing the dose of radiotherapy to the main bulk of tumor may improve the symptom-free survival or overall survival in patients who present with brain metastases as the sole site of extrathoracic disease.
Adenocarcinoma
;
Brain
;
Carcinoma, Large Cell
;
Carcinoma, Non-Small-Cell Lung
;
Carcinoma, Squamous Cell
;
Female
;
Humans
;
Lung*
;
Male
;
Neoplasm Metastasis*
;
Radiation Oncology
;
Radiotherapy
;
Retrospective Studies
9.Congenital Adrenal Hyperplasia with 21-hydroxylase Deficiencies in Twins.
Young Don KIM ; Jeong Hwa CHOI ; Jae Hong PARK ; Hee Ju PARK ; Seong Suk JEON
Journal of the Korean Pediatric Society 1994;37(10):1469-1473
Congenital adrenal hyperplasia is inherited disorder of adrenal steroidogenesis. 21-hydroxylase deficiency is the most commone enzymatic defect and is divided into classic and late-onset or nonclassic forms. Both classic non-classic 21-hydrozylase deficiencies are inherited in a recessive manner as allelic variants. But it is rare that happened in twin infants. Chief complaints of affected twins in our case were ambiguous genitalia, hyperpigmentation and dehydrations. They were revealed into hyponatremia, hyperkalemia and increased amount of serum progesterone, 17-hydroxyprogesterone and urinary 17-ketosteroid excretion and were administered with DOCA, 9alpha-fluorohydrocortisone, hydrocortisone to control the electrolyte imbalance. And now, both of them are going to normal ratio of weight gain and body growth.
17-alpha-Hydroxyprogesterone
;
Adrenal Hyperplasia, Congenital*
;
Desoxycorticosterone Acetate
;
Disorders of Sex Development
;
Humans
;
Hydrocortisone
;
Hyperkalemia
;
Hyperpigmentation
;
Hyponatremia
;
Infant
;
Progesterone
;
Steroid 21-Hydroxylase*
;
Twins*
;
Weight Gain
10.Postoperative Radiation Therapy of Astrocytoma and Glioblastoma Multiforme.
Moon Baik PARK ; Seong Eon HONG
Journal of the Korean Society for Therapeutic Radiology 1989;7(1):23-28
Forty-four patients with brain astrocytoma and glioblastoma were treated with surgical resection and postoperative radiation from January 1980 through May 1987. Four patients were lost to follow up, and in 40 patients sruvival time was evaluable. Three year actuarial sruvival rate was 66.7% in Grade I and II astrocytoma, 30% in Grade III, and 20.4% in glioblastoma multiforme patients. The prognostic factors affecting survival rate were histologic grade in all cases, age, and total radiation dose in Grade III and glioblastoma.
Astrocytoma*
;
Brain
;
Glioblastoma*
;
Humans
;
Lost to Follow-Up
;
Survival Rate